IL0010941198

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies

July 20, 2026 07:00 ET  | Source: Kamada Ltd. REHOVOT, Israel and HOBOKEN, N.J., July 20, 2026 (GLOBE NEWSWIRE) --…

5 days ago

Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026

Company to Host Conference Call at 8:30am ET March 04, 2026 07:00 ET  | Source: Kamada Ltd. REHOVOT, Israel, and…

5 months ago